Results 11 to 20 of about 784,373 (290)

Juvenile idiopathic arthritis

open access: yesNature Reviews Disease Primers, 2022
Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting for >6 weeks with onset before 16 years of age. JIA is the most common chronic inflammatory rheumatic condition of childhood. According to the International League Against Rheumatism (ILAR) classification, seven mutually exclusive categories of JIA exist ...
Alberto Martini   +6 more
openaire   +3 more sources

Classifications and imaging of juvenile spondyloarthritis [PDF]

open access: yesJournal of Ultrasonography, 2018
Juvenile spondyloarthritis may be present in at least 3 subtypes of juvenile idiopathic arthritis according to the classification of the International League of Associations for Rheumatology.
Iwona Sudoł-Szopińska   +5 more
doaj   +3 more sources

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

open access: yesArthritis care & research, 2022
To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint (TMJ) arthritis, and systemic JIA with and without macrophage activation syndrome ...
K. Onel   +36 more
semanticscholar   +1 more source

Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus‐Based Recommendations

open access: yesArthritis & Rheumatology, 2022
Involvement of the temporomandibular joint (TMJ) is common in juvenile idiopathic arthritis (JIA). TMJ arthritis can lead to orofacial symptoms, orofacial dysfunction, and dentofacial deformity with negative impact on quality of life. Management involves
P. Stoustrup   +29 more
semanticscholar   +1 more source

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

open access: yesArthritis care & research, 2022
To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication monitoring, immunizations, and imaging, irrespective of JIA phenotype.
K. Onel   +36 more
semanticscholar   +1 more source

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches

open access: yesPediatric Rheumatology Online Journal, 2021
Juvenile idiopathic arthritis (JIA) is the most common paediatric rheumatological disorder and is classified by subtype according to International League of Associations for Rheumatology criteria.
L. Zaripova   +5 more
semanticscholar   +1 more source

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis

open access: yesArthritis & Rheumatology, 2021
To develop and validate new Juvenile Arthritis Disease Activity Score 10 (JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive disease (ID), minimal disease activity (MiDA), moderate disease activity (MoDA), and high ...
C. Trincianti   +20 more
semanticscholar   +1 more source

Effect of Clonally Expanded PD‐1highCXCR5–CD4+ Peripheral T Helper Cells on B Cell Differentiation in the Joints of Patients With Antinuclear Antibody–Positive Juvenile Idiopathic Arthritis

open access: yesArthritis & Rheumatology, 2021
Antinuclear antibody (ANA)–positive juvenile idiopathic arthritis (JIA) is characterized by synovial B cell hyperactivity, but the precise role of CD4+ T cells in promoting local B cell activation is unknown.
J. Fischer   +8 more
semanticscholar   +1 more source

LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages

open access: yesJournal of Experimental Medicine, 2021
Juvenile arthritis represents the most common rheumatic manifestation in children. LACC1 deficiency has been identified as a monogenic cause of juvenile arthritis. In this issue, Omarjee et al.
Ommar Omarjee   +28 more
semanticscholar   +1 more source

Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study

open access: yesArthritis & Rheumatology, 2021
To investigate the effects of early introduction of biologic disease‐modifying antirheumatic drugs (bDMARDs) on the disease course in untreated polyarticular juvenile idiopathic arthritis (JIA).
Mei‐Sing Ong   +499 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy